Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at http://www.fivestarequities.com/ and get exclusive access to our numerous stock reports.
CEL-SCI Corporation (NYSEMKT: CVM) shares dropped 32.34 percent to close at $0.839 a share last Tuesday. The stock traded between $0.83 and $0.92 on volume 8.28 million shares traded. The company has recently announced the pricing of a $17.8 million public offering of common stock and warrants. Shares of CEL-SCI have fallen approximately 70.0 percent year-to-date.
Get more information on CEL-SCI free access to the in-depth equity report at:
Idenix Pharmaceuticals Inc. (NASDAQ: IDIX) shares fell 16.18 percent to close at $3.99 a share last Tuesday. The stock traded between $3.66 and $4.79 on volume 4.72 million shares traded. Shares declined after partner Johnson & Johnson purchased a rival company’s treatment for hepatitis C. Shares of Idenix Pharmaceuticals have fallen approximately 18.0 percent year-to-date.
Get more information on Idenix Pharmaceuticals and free access to the in-depth equity report at:
McKesson Corporation (NYSE: MCK) shares increased 3.16 percent to close at $133.72 a share last Tuesday. The stock traded between $133.38 and $138.43 on volume of 6.32 million shares traded. The company is currently in negotiations with the majority shareholder of Celesio AG to purchase the rival German drug maker. Shares of McKesson have gained approximately 38.0 percent year-to-date.
Get more information on McKesson and free access to the in-depth equity report at:
Talisman Energy Inc. (NYSE: TLM)(TSX: TLM) shares declined 2.35 percent to close at $12.45 a share last Tuesday. The stock traded between $12.40 and $13.38 on volume of 53.41 million shares traded. Carl Icahn has announced that he holds nearly a 6.0 percent stake in the company. Shares of Talisman Energy have gained approximately 10.0 percent year-to-date.
Get more information on Talisman Energy and free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities
Leave a comment...